Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Piper Sandler Companies Common Stock (NY:PIPR)

234.60 -24.36 (-9.41%)
Streaming Delayed Price Updated: 1:35 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Piper Sandler Companies Common Stock

< Previous 1 2 3 4 5 6 7 Next >
3 Magnificent Growth Stocks to Buy Hand Over Fist With $500
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Investors Thought Freshpet Stock Was a bad boy Today
Via The Motley Fool
What's Driving the Market Sentiment Around Piper Sandler?
Via Benzinga
Top 3 Financial Stocks That Could Blast Off This Month
Via Benzinga
Why Hims & Hers Stock Rebounded on Wednesday
Via The Motley Fool
Piper Sandler: Q4 Earnings Insights
Via Benzinga
(PIPR) - Analyzing Piper Sandler's Short Interest
Via Benzinga
Peering Into Piper Sandler's Recent Short Interest
Via Benzinga
(PIPR) - Analyzing Piper Sandler's Short Interest
Via Benzinga
Earnings Scheduled For January 31, 2025
Via Benzinga
With M&A Activity Heating Up, These Investment Banking Stocks Should Rise
There have already been a few big deals announced in the first two weeks of 2025 – with more expected. 
Via Talk Markets
Topics Stocks / Equities
Prediction: 2 Brilliant Stocks Will Be Worth More Than Palantir Technologies by Year's End in 2025
Via The Motley Fool
How Is The Market Feeling About Piper Sandler?
Via Benzinga
Earnings Outlook For Piper Sandler
Via Benzinga
Is Nike Stock in Trouble?
Nike's stock is trading around multi-year lows. 
Via The Motley Fool
How Is The Market Feeling About Piper Sandler?
Via Benzinga
Cut in Half This Year, Can Celsius Stock Rebound in 2025?
Via The Motley Fool
Trump Trade Sparks Biggest Financial Stock Inflows In 2 Years
Financial stocks rally after Trump's return to White House; investors expect deregulation and tax cuts. Goldman Sachs predicts top picks in sector. 
Via Benzinga
Topics Government
Exposures Political
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
How Is The Market Feeling About Piper Sandler?
Via Benzinga
History Says the S&P 500 Could Jump in November: 2 No-Brainer Stocks to Buy With $100 Right Now
Strong competitive positions make Shopify and Uber no-brainer buys in November. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
LPL Financial Holdings Stock Flashes Improved Relative Price Strength
On Tuesday, LPL Financial Holdings stock earned an upgrade to its Relative Strength (RS) Rating, from 67 to 71. 
Via Investor's Business Daily
Should You Buy e.l.f. Beauty Stock Before Nov. 6?
The brand is gaining market share in cosmetics, but a weak sales environment creates uncertainty heading into the next earnings report. 
Via The Motley Fool
Why Investors Hit the Brakes on Polestar Stock Today
No one likes a drastic price target reduction. 
Via The Motley Fool
2 Top Stocks to Buy Now, According to Wall Street
Recent developments point to a lucrative opportunity for investors in these stocks. 
Via The Motley Fool
2 Game-Changing Artificial Intelligence (AI) Stocks to Buy Now That Could Help Set You Up for Life
Here's how to claim your share of the AI gold rush. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Estee Lauder Stock Was Smelling Sweet on Thursday
A pundit's move gave the company a bit of a spark on an otherwise uninspiring day for the market. 
Via The Motley Fool
7 A-Rated Growth Stocks to Buy in August 2024
Many A-rated growth stocks are on sale because of the recent market downturn. That makes this an ideal time to buy. 
Via InvestorPlace
3 Financial Stocks to Sell in August Before They Crash & Burn
The stock market took an abrupt turn lower over the past month. That makes it a great time to sell these risky financial stocks. 
Via InvestorPlace
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?
Find out how concerned investors should be about setbacks for this company's revolutionary new cancer therapies. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.